Publications - RTI Health Solutions

Publications

Full Publications List (1537 results)

Search Publications

Displaying 341 through 360 of 1537 items.

« Previous Page 1 10 11 12 13 14 15 16 17 18 19 20 30 40 50 60 70 77 Next » [Show All]

2011

Karve, S.J., R. Balkrishnan, Y.M. Mohammad, and D.A. Levine. (2011). "Racial/Ethnic Disparities in Emergency Department Waiting Time for Stroke Patients in the United States." Journal of Stroke and Cerebrovascular Diseases, 20(1):30-40.

Emergency department waiting time (EDWT), the time from arrival at the ED to evaluation by an emergency physician, is a critical component of acute stroke care. We assessed racial/ethnic differences... Full Abstract »

Gutierrez, L., N. Roskell, J. Castellsague, S. Beard, C. Rycroft, S. Abeysinghe, P. Shannon, S. Robbins, and M. Gitlin. (2011). "Study of the incremental cost and clinical burden of hip fractures in postmenopausal women in the United Kingdom." Journal of Medical Economics, 14(1):99-107.

OBJECTIVE: To determine the incremental cost of healthcare and clinical outcomes in the 12 months following incident hip fractures among postmenopausal women in the UK. METHODS: Retrospective cohort... Full Abstract »

Gillig, M.K., and Q. Smith. (2011). "Teaching and communicating are key to proving value." Journal of Pharmaceutical Sciences, 11(2):33-44.

2010

Mauskopf, J., L. Annemans, A.M. Hill, and E. Smets. (2010). "A review of economic evaluations of darunavir boosted by low-dose ritonavir in treatment-experienced persons living with HIV infection." Pharmacoeconomics, 28 Suppl 1:1-16.

Darunavir boosted by low-dose ritonavir (DRV/r), at a daily dose of 600/100 mg twice a day (bid), has been shown to be superior to alternative highly active antiretroviral therapy (HAART) regimens... Full Abstract »

Mauskopf, J., A. Brogan, S. Martin, and E. Smets. (2010). "Cost effectiveness of darunavir/ritonavir in highly treatment-experienced, HIV-1-infected adults in the USA." Pharmacoeconomics, 28 Suppl 1:83-105.

INTRODUCTION: Darunavir is a new protease inhibitor (PI) that is co-administered with low-dose ritonavir and has demonstrated substantial efficacy in clinical trials of highly treatment-experienced... Full Abstract »

Colin, X., A. Lafuma, D. Costagliola, E. Smets, J. Mauskopf, and P. Guillon. (2010). "Modelling the budget impact of darunavir in the treatment of highly treatment-experienced, HIV-infected adults in France." Pharmacoeconomics, 28(Suppl 1):183-197.

BACKGROUND: A key element for payers in the assessment of the economic profile of a medication is its anticipated impact on the evolution of healthcare budgets. OBJECTIVES: To forecast the impact of... Full Abstract »

Brogan, A., J. Mauskopf, S.E. Talbird, and E. Smets. (2010). "US cost effectiveness of darunavir/ritonavir 600/100 mg bid in treatment-experienced, HIV-infected adults with evidence of protease inhibitor resistance included in the TITAN Trial." Pharmacoeconomics, 28(Suppl 1):129-146.

INTRODUCTION: The phase III TITAN trial evaluated the use of darunavir with low-dose ritonavir (DRV/r) 600/100 mg twice daily (bid) compared with lopinavir with low-dose ritonavir (LPV/r) in... Full Abstract »

Khilko, N., J. Wang, B. Wei, D.G. Hicks, and P. Tang. (2010). "Invasive lobular carcinomas do not express basal cytokeratin markers CK5/6, CK14 and CK17." Breast Cancer: Basic and Clinical Research, 2010(4):49-55.

The expression of basal cytokeratin markers CK5/6 in breast carcinomas has been associated with high histological grade and poor clinical outcome. A previous study has shown that CK5/6 can be... Full Abstract »

Chung, R.T., F.F. Poordad, T. Hassanein, X. Zhou, E. Lentz, A. Prabhakar, and A.M. Di Bisceglie. (2010). "Association of host pharmacodynamic effects with virologic response to pegylated interferon alfa-2a/ribavirin in chronic hepatitis C." Hepatology, 52(6):1906-1914.

Patients receiving therapy for chronic hepatitis C virus (HCV) infection frequently experience cytopenias and weight loss. We retrospectively assessed the pharmacodynamic effects of pegylated... Full Abstract »

Chung, R.T., F.F. Poordad, T. Hassanein, X.L. Zhou, E. Lentz, A. Prabhakar, and A.M. Di Bisceglie. (2010). "Association of Host Pharmacodynamic Effects with Virologic Response to Pegylated Interferon alfa-2a/Ribavirin in Chronic Hepatitis C." Hepatology, 52(6):1906-1914.

Patients receiving therapy for chronic hepatitis C virus (HCV) infection frequently experience cytopenias and weight loss We retrospectively assessed the pharmacodynamic effects of pegylated... Full Abstract »

Marshall, D., J.F.P. Bridges, B. Hauber, R. Cameron, L. Donnalley, K. Fyie, and F.R. Johnson. (2010). "Conjoint analysis applications in health - How are studies being designed and reported?: An update on current practice in the published literature between 2005 and 2008." Patient: Patient-Centered Outcomes Research, 3(4):249-256.

Despite the increased popularity of conjoint analysis in health outcomes research, little is known about what specific methods are being used for the design and reporting of these studies. This... Full Abstract »

Wang, J., B. Sherrill, L.A. Hamm, and A.W. Mangel. (2010). "Does timing of colon procedures affect outcomes in D-IBS trials?." Gastroenterology Research, 3(5):185-190.

Background: Sigmoidoscopy/colonoscopy is usually performed prior to enrollment into clinical trials of irritable bowel syndrome (IBS). Two main reasons are to rule out alternative diagnoses and to... Full Abstract »

Meyers, J., P. Classi, L. Wietecha, and S. Candrilli. (2010). "Economic burden and comorbidities of attention-deficit/hyperactivity disorder among pediatric patients hospitalized in the United States." Child Adolesc Psychiatry Ment Health, 4:31-.

ABSTRACT: BACKGROUND: This retrospective database analysis used data from the Healthcare Cost and Utilization Project's Nationwide Inpatient Sample (NIS) to examine common primary diagnoses among... Full Abstract »

McKenna, S.P., L.C. Doward, J. Twiss, P. Hagell, N.C. Oprandi, J. Fisk, F. Grand'Maison, V. Bhan, T. Arbizu, D. Brassat, T. Kohlmann, D.M. Meads, and B.J. Eckert. (2010). "International development of the Patient-Reported Outcome Indices for Multiple Sclerosis (PRIMUS)." Value in Health, 13(8):946-951.

Background The Patient-Reported Indices for Multiple Sclerosis (PRIMUS) comprises a suite of three scales for assessing symptoms, activity limitations, and quality of life in multiple sclerosis (MS).... Full Abstract »

Lang, K., J.L. Meyers, J.R. Korn, S. Lee, M. Sikirica, C. Crivera, R. Dirani, and J. Menzin. (2010). "Medication adherence and hospitalization among patients with schizophrenia treated with antipsychotics." Psychiatric Services, 61(12):1239-1247.

OBJECTIVE: This analysis assessed rates of medication adherence and predictors of nonadherence and hospitalization among patients treated with long-acting injectable and oral antipsychotic therapies.... Full Abstract »

Mohamed, A.F., A.B. Hauber, F.R. Johnson, and C.D. Coon . (2010). "Patient preferences and linear scoring rules for patient-reported outcomes." Patient: Patient-Centered Outcomes Research, 3(4):217-227.

Background: Many patient-reported outcomes (PRO) instruments are scored by averaging or summing Likert category values over all items or domains of the elicitation instrument, yielding... Full Abstract »

Earnshaw, S.R., Y. Yih, T.N. Taylor, and C. McDade. (2010). "Pharmacoeconomics and the drug development process." In Handbook of Healthcare Delivery Systems Boca Raton, FL: CRC Press.

Vinceti, M., F. Bonvicini, K.J. Rothman, L. Vescovi, and F.Y. Wang. (2010). "The relation between amyotrophic lateral sclerosis and inorganic selenium in drinking water: a population-based case-control study." Environmental Health, 9(Art. No. 77).

Background: A community in northern Italy was previously reported to have an excess incidence of amyotrophic lateral sclerosis among residents exposed to high levels of inorganic selenium in their... Full Abstract »

Roskell, N.S., G.Y. Lip, H. Noack, A. Clemens, and J.M. Plumb. (2010). "Treatments for stroke prevention in atrial fibrillation: A network meta-analysis and indirect comparisons versus dabigatran etexilate." Thrombosis and Haemostasis, 104(6):1106-1115.

Patients with atrial fibrillation at moderate to high risk of stroke are not always anticoagulated despite a lack of contraindications to vitamin K antagonists (VKAs) like warfarin. These patients... Full Abstract »

Dalal, A.A., C. Demuro-Mercon, S. Lewis, L. Nelson , T. Gilligan, and L. McLeod. (2010). "Validation of alternate modes of administration of the lung function questionnaire (LFQ) in subjects with smoking history." International Journal of Chronic Obstructive Pulmonary Disease, 5:425-434.

Purpose: The Lung Function Questionnaire (LFQ) was developed and validated as a case-finding tool to identify patients at risk of airflow obstruction (AO) that should be evaluated further using... Full Abstract »

Displaying 341 through 360 of 1537 items.

« Previous Page 1 10 11 12 13 14 15 16 17 18 19 20 30 40 50 60 70 77 Next » [Show All]